Chem Shift validation: AVS_full
BMRB Entry DOI: doi:10.13018/BMR50283
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Wallerstein, Johan; Ekberg, Vilhelm; Misini Ignjatovic, Majda; Kumar, Rohit; Caldararu, Octav; Peterson, Kristoffer; Wernersson, Sven; Brath, Ulrika; Leffler, Hakon; Oksanen, Esko; Logan, Derek; Nilsson, Ulf; Ryde, Ulf; Akke, Mikael. "Entropy-Entropy Compensation between the Protein, Ligand, and Solvent Degrees of Freedom Fine-Tunes Affinity in Ligand Binding to Galectin-3C" JACS Au. 1, 484-500 (2021).
Assembly members:
entity_1, polymer, . residues, Formula weight is not available
entity_KOW, non-polymer, 503.499 Da.
Natural source: Common Name: Human Taxonomy ID: 9606 Superkingdom: Eukaryota Kingdom: Metazoa Genus/species: Homo sapiens
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: pLysS pGal3CRD
Entity Sequences (FASTA):
entity_1: PLIVPYNLPLPGGVVPRMLI
TILGTVKPNANRIALDFQRG
NDVAFHFNPRFNENNRRVIV
CNTKLDNNWGREERQSVFPF
ESGKPFKIQVLVEPDHFKVA
VNDAHLLQYNHRVKKLNEIS
KLGISGDIDLTSASYTMI
Data type | Count |
13C chemical shifts | 85 |
15N chemical shifts | 122 |
1H chemical shifts | 377 |
T1 relaxation values | 365 |
T2 relaxation values | 365 |
heteronuclear NOE values | 365 |
order parameters | 189 |
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | gal3C | 1 |
2 | ligand M | 2 |
Entity 1, gal3C - Formula weight is not available
1 | PRO | LEU | ILE | VAL | PRO | TYR | ASN | LEU | PRO | LEU | ||||
2 | PRO | GLY | GLY | VAL | VAL | PRO | ARG | MET | LEU | ILE | ||||
3 | THR | ILE | LEU | GLY | THR | VAL | LYS | PRO | ASN | ALA | ||||
4 | ASN | ARG | ILE | ALA | LEU | ASP | PHE | GLN | ARG | GLY | ||||
5 | ASN | ASP | VAL | ALA | PHE | HIS | PHE | ASN | PRO | ARG | ||||
6 | PHE | ASN | GLU | ASN | ASN | ARG | ARG | VAL | ILE | VAL | ||||
7 | CYS | ASN | THR | LYS | LEU | ASP | ASN | ASN | TRP | GLY | ||||
8 | ARG | GLU | GLU | ARG | GLN | SER | VAL | PHE | PRO | PHE | ||||
9 | GLU | SER | GLY | LYS | PRO | PHE | LYS | ILE | GLN | VAL | ||||
10 | LEU | VAL | GLU | PRO | ASP | HIS | PHE | LYS | VAL | ALA | ||||
11 | VAL | ASN | ASP | ALA | HIS | LEU | LEU | GLN | TYR | ASN | ||||
12 | HIS | ARG | VAL | LYS | LYS | LEU | ASN | GLU | ILE | SER | ||||
13 | LYS | LEU | GLY | ILE | SER | GLY | ASP | ILE | ASP | LEU | ||||
14 | THR | SER | ALA | SER | TYR | THR | MET | ILE |
Entity 2, ligand M - C20 H26 F N3 O9 S - 503.499 Da.
1 | KOW |
Download HSQC peak lists in one of the following formats:
CSV: Backbone
or all simulated peaks
SPARKY: Backbone
or all simulated peaks